MOLECULAR DYNAMIC SIMULATION OF ASIATIC ACID DERIVATIVES COMPLEX WITH INDUCIBLE NITRIC OXIDE SYNTHASE ENZYME AS AN ANTI-INFLAMMATORY
Objective: The aim of this study was to determine the stability interaction of asiatic acid derivatives (AA) complex with inducible nitric oxide synthase (iNOS) enzyme as an anti-inflammatory using Molecular Dynamic (MD) simulation.
Methods: The methods were consisting of validation of molecular docking, molecular docking to calculate binding affinity within the complex between the compounds and iNOS enzyme by using MMGBSA (Molecular Mechanics/Generalized Born Surface Area), and MD system preparation, MD production as well as MD analysis using AMBER18.
Results: The result of validation and molecular docking were AA5 has the most negative Gibbs energy that is -9.17 kcal/mol, which has better binding affinity than other derivatives than other derivatives. The molecular dynamics simulation of the modified structure of asiatic acid showed that binding energy value and RMSD of AA5, AA6 and AA9 have a lower value compared to arginine as a substrate of iNOS enzyme. Molecular Dynamics that have been occurred to the best three compounds chosen shown good result in terms of stability after 100 ns length simulation. And the lowest binding affinity has been achieved by a compound called AA5. Out of all ligands that have been simulated shown that their binding affinity was lower than AA5 that reached-44.6753 kcal/mol.
Conclusion: This studies conclude that AA5 considerably more potential as a selective inhibitor of iNOS enzyme as an anti-inflammatory.
2. Vítecek J, Lojek A, Valacchi G, Kubala L. Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges. Mediators Inflamm 2012. https://doi.org/ 10.1155/2012/318087.
3. Hamalainen M. Inducible nitric oxide synthase as a target of treatment modalities; 2008.
4. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J 2012;33:829-37.
5. Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol 2015;36:161-78.
6. Nakazawa H, Chang K, Shinozaki S. iNOS as a driver of inflammation and apoptosis in mouse skeletal muscle after burn injury: possible involvement of sirt1 S-nitrosylation-mediated acetylation of p65 NFe?B and p53. PLoS One 2017;12:1-18.
7. Lv J, Sharma A, Zhang T, Wu Y, Ding X. Pharmacological review on asiatic acid and its derivatives: a potential compound. SLAS Technol 2018;23:111-27.
8. Huang SS, Chiu CS, Chen HJ. Antinociceptive activities and the mechanisms of anti-inflammation of asiatic acid in mice. Evidence-Based Complement Altern Med 2011. DOI:10.1155/2011/895857.
9. Marbun EMA, Restuati M. Pengaruh ektrak etanol daun buas-buas (premna pubescens blume) sebagai antiinflamasi pada edema kaki tikus putih (Rattus novergicus). J Biosains 2015;1:107-22.
10. Gohil KJ, Patel JA, Gajjar AK. Pharmacological review on centella asiatica: a potential herbal cure-all. Indian J Pharm Sci 2010;72:546.
11. Hashim P, Sidek H, Helan MHM, Sabery A, Palanisamy UD, Ilham M. Triterpene composition and bioactivities of centella asiatica. Molecules 2011;16:1310-22.
12. Musfiroh I, Nursamsiar, Muhtadi A, Kartasasmita RE, Tjahjono DH, Slamet Ibrahim S. In silico study of asiatic acid interaction with inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Int J Pharm Pharm Sci 2013;5(Suppl 1):204-7.
13. Musfiroh I, Sri Rizky W, Winasih, Muhtadi A, Kartasasmita RE, Ibrahim S. QSAR study of asiatic acid and its derivatives as potential inducible nitric oxide synthase (iNOS) inhibitors. Int J Chem Sci 2015;13:1459-73.
14. Musfiroh I, Septiandi I, Megantara S, Tjitraresmi A, Muchtaridi. Interaction analysis of asiatic acid and its derivatives to three isozyme of nitric oxide synthase (NOS) using molecular docking. Res J Chem Environ 2019;23:87-93.
15. Meng Y, Sabri Dashti D, Roitberg AE. Computing alchemical free energy differences with hamiltonian replica exchange molecular dynamics (H-REMD) simulations. J Chem Theory Comput 2011;7:2721-7.
16. If’all I, Hasanuddin A, Rahim A, Kadir S. Modifikasi pati secara asetilasi terhadap gugus fungsi asetil dan kristanilitas pati ubi banggai asetat. Rekayasa 2019;12:135-40.
17. Poulos TL, Li H. Nitric oxide synthase and structure-based inhibitor design. Nitric Oxide Biol Chem 2017;63:68-77.
18. Azam F, Abugrain IM, Sanalla MH, Elnaas RF, Rajab I. In silico investigation of the structural requirements for the AMPA receptor antagonism by quinoxaline derivatives. Bio information 2013;9:864-9.
19. Roy J, Laughton CA. Long-time-scale molecular-dynamics simulations of the major urinary protein provide atomistic interpretations of the unusual thermodynamics of ligand binding. Biophys J 2010;99:218-26.
20. Du X, Li Y, Xia YL. Insights into protein-ligand interactions: mechanisms, models, and methods. Int J Mol Sci 2016;17:1-34.
21. Chang MW, Ayeni C, Breuer S, Torbett BE. Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and vina. PLoS One 2010;5:e11955.
22. Hospital A, Goñi JR, Orozco M, Gelpi JL. Molecular dynamics simulations: advances and applications. Adv Appl Bioinforma Chem 2015;8:37-47.
23. Bowman GR. Accurately modeling nanosecond protein dynamics requires at least microseconds of simulation. J Comput Chem 2016;37:558-66.
24. Abdulazeez S. Molecular simulation studies on B-cell lymphoma/leukaemia 11A (BCL11A). Am J Transl Res 2019;11:3689-97.
25. Sargsyan K, Grauffel C, Lim C. How molecular size impacts RMSD applications in molecular dynamics simulations. J Chem Theory Comput 2017;13:1518-24.
26. Maulana FA, Ambarsari L, Wahyudi ST. Homology modeling and structural dynamics of the glucose oxidase. Indones J Chem 2020;20:43-53.
27. Barrientos A, Concha F. Phenomenological model of classification in conventional hydrocylones. Comminution 1990;819:287-305.
28. Hansson T, Marelius J, Aqvist J. Ligand binding affinity prediction by linear interaction energy methods. J Comput Aided Mol Des 1998;12:27-35.
29. Wickstrom L, Gallicchio E, Levy RM. The linear interaction energy method for the prediction of protein stability changes upon mutation. Proteins Struct Funct Bioinforma 2012;80:111-25.
30. Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discovery 2015;10:449-61.
31. Virtanen SI, Niinivehmas SP, Pentikäinen OT. Case-specific performance of MM-PBSA, MM-GBSA, and SIE in virtual screening. J Mol Graph Model 2015;62:303-18.
32. Sun H, Duan L, Chen F. Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches. Phys Chem Chem Phys 2018;20:14450-60.
This work is licensed under a Creative Commons Attribution 4.0 International License.